{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:04:27Z","timestamp":1778828667590,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/ico.0b013e3181a16472","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T14:48:37Z","timestamp":1258728517000},"page":"1091-1096","source":"Crossref","is-referenced-by-count":80,"title":["High-frequency Topical Cyclosporine 0.05% in the Treatment of Severe Dry Eye Refractory to Twice-daily Regimen"],"prefix":"10.1097","volume":"28","author":[{"given":"Mohammad H","family":"Dastjerdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Hamrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210204","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"R2-2-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"R3-2-20210204","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0161-6420(86)33528-0","article-title":"The autoimmune nature of aqueous tear deficiency.","volume":"93","author":"Pflugfelder","year":"1986","journal-title":"Ophthalmology"},{"key":"R4-2-20210204","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-2-20210204","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bjo.57.11.852","article-title":"Histology of the lacrimal gland in keratoconjunctivitis sicca.","volume":"57","author":"Williamson","year":"1973","journal-title":"Br J Ophthalmol"},{"key":"R6-2-20210204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exer.2003.09.003","article-title":"The role of the lacrimal functional unit in the pathophysiology of dry eye.","volume":"78","author":"Stern","year":"2004","journal-title":"Exp Eye Res"},{"key":"R7-2-20210204","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","article-title":"The diagnosis and management of dry eye: a twenty-five-year review.","volume":"19","author":"Pflugfelder","year":"2000","journal-title":"Cornea"},{"key":"R8-2-20210204","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R9-2-20210204","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","article-title":"Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion.","volume":"19","author":"Turner","year":"2000","journal-title":"Cornea"},{"key":"R10-2-20210204","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","article-title":"Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogrens syndrome.","volume":"72","author":"Gunduz","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R11-2-20210204","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00003226-199307000-00007","article-title":"Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca.","volume":"12","author":"Laibovitz","year":"1993","journal-title":"Cornea"},{"key":"R12-2-20210204","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","article-title":"Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"R13-2-20210204","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"R14-2-20210204","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3565(25)24259-8","article-title":"Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporine.","volume":"244","author":"Babany","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-2-20210204","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes.","volume":"21","author":"Lemp","year":"1995","journal-title":"Clao J"},{"key":"R16-2-20210204","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD.","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"key":"R17-2-20210204","first-page":"69","article-title":"Chronic graft-versus-host disease.","volume":"5","author":"Atkinson","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"R18-2-20210204","first-page":"7","article-title":"Cyclosporin a: a new era in organ transplantation.","volume":"10","author":"DeBakey","year":"1984","journal-title":"Compr Ther"},{"key":"R19-2-20210204","first-page":"S101","article-title":"Benefit\/risk of cyclosporine in rheumatoid arthritis.","volume":"22","author":"Gremese","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R20-2-20210204","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1582-4934.2004.tb00321.x","article-title":"Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease.","volume":"8","author":"Kountouras","year":"2004","journal-title":"J Cell Mol Med"},{"key":"R21-2-20210204","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2230.2002.01148.x","article-title":"Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology.","volume":"27","author":"Reynolds","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"R22-2-20210204","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","article-title":"Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis.","volume":"112","author":"Nussenblatt","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R23-2-20210204","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcets disease.","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"R24-2-20210204","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0161-6420(13)31254-8","article-title":"Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy.","volume":"101","author":"Vitale","year":"1994","journal-title":"Ophthalmology"},{"key":"R25-2-20210204","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10384-004-0098-3","article-title":"Effect of immunosuppression on survival of allograft limbal stem cells.","volume":"48","author":"Chen","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"R26-2-20210204","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporine A delivery to the eye: a pharmaceutical challenge.","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"key":"R27-2-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ceyr.18.2.91.5381","article-title":"Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs.","volume":"18","author":"Acheampong","year":"1999","journal-title":"Curr Eye Res"},{"key":"R28-2-20210204","first-page":"519","article-title":"Pharmacokinetic of topical cyclosporin A in the rabbit eye.","volume":"27","author":"Wiederholt","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-2-20210204","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/978-1-4615-5359-5_144","article-title":"Cyclosporine distribution into the conjunctiva, cornea, lacrimal gland, and systemic blood following topical dosing of cyclosporine to rabbit, dog, and human eyes.","volume":"438","author":"Acheampong","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R30-2-20210204","first-page":"119","article-title":"Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.","volume":"20","author":"Kanpolat","year":"1994","journal-title":"Clao J"},{"key":"R31-2-20210204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archopht.1985.01050010107030","article-title":"Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum.","volume":"103","author":"Mosteller","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R32-2-20210204","first-page":"1362","article-title":"Ocular penetration of cyclosporin A. The rabbit eye.","volume":"31","author":"BenEzra","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-2-20210204","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-200544030-00003","article-title":"Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye.","volume":"44","author":"Tang-Liu","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R34-2-20210204","first-page":"27","article-title":"Pharmacologic aspects of cyclosporine therapy: pharmacokinetics.","volume":"17","author":"Wood","year":"1985","journal-title":"Transplant Proc"},{"key":"R35-2-20210204","first-page":"1667","article-title":"The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.","volume":"17","author":"Britton","year":"1985","journal-title":"Transplant Proc"},{"key":"R36-2-20210204","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3565(25)24163-5","article-title":"In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.","volume":"248","author":"Babany","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"R37-2-20210204","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09273940701299354","article-title":"Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.","volume":"15","author":"Cordero-Coma","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"key":"R38-2-20210204","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/10807680260362696","article-title":"Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease.","volume":"18","author":"Small","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"R39-2-20210204","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/978-1-4615-5359-5_142","article-title":"Preclinical safety studies of cyclosporine ophthalmic emulsion.","volume":"438","author":"Angelov","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"R40-2-20210204","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ophtha.2003.07.008","article-title":"Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.","volume":"111","author":"Di Pascuale","year":"2004","journal-title":"Ophthalmology"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e3181a16472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:12:52Z","timestamp":1739441572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-200912000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181a16472","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}